ArticleBiomarkers in medicine2025
mSEPT9 performs better than CEA in NAT response and MRD assessment and recurrence prediction of stage III CRC.
Jianbiao Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it